137 related articles for article (PubMed ID: 21279349)
1. FDG PET coregistered to MRI for diagnosis and monitoring of therapeutic response in aggressive phenotype of sarcoidosis.
Imperiale A; Riehm S; Veillon F; Namer IJ; Braun JJ
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):983-4. PubMed ID: 21279349
[No Abstract] [Full Text] [Related]
2. The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients.
Promteangtrong C; Salavati A; Cheng G; Torigian DA; Alavi A
Hell J Nucl Med; 2014; 17(2):123-35. PubMed ID: 25097898
[TBL] [Abstract][Full Text] [Related]
3. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
Ohira H; Tsujino I; Ishimaru S; Oyama N; Takei T; Tsukamoto E; Miura M; Sakaue S; Tamaki N; Nishimura M
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT.
Matthews R; Bench T; Meng H; Franceschi D; Relan N; Brown DL
J Nucl Cardiol; 2012 Aug; 19(4):807-10. PubMed ID: 22466988
[No Abstract] [Full Text] [Related]
5. [Application of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis and therapy of patients with sarcoidosis].
Li D; Lü PX
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):447-50. PubMed ID: 24103209
[No Abstract] [Full Text] [Related]
6. Advanced imaging of cardiac sarcoidosis.
Schatka I; Bengel FM
J Nucl Med; 2014 Jan; 55(1):99-106. PubMed ID: 24232870
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging in sarcoidosis.
Mañá J; Gámez C
Curr Opin Pulm Med; 2011 Sep; 17(5):325-31. PubMed ID: 21597377
[TBL] [Abstract][Full Text] [Related]
8. FDG PET imaging in sarcoidosis.
Sobic-Saranovic D; Artiko V; Obradovic V
Semin Nucl Med; 2013 Nov; 43(6):404-11. PubMed ID: 24094707
[TBL] [Abstract][Full Text] [Related]
9. Imaging in sinonasal sarcoidosis: CT, MRI, 67Gallium scintigraphy and 18F-FDG PET/CT features.
Braun JJ; Imperiale A; Riehm S; Veillon F
J Neuroradiol; 2010 Jul; 37(3):172-81. PubMed ID: 19959235
[TBL] [Abstract][Full Text] [Related]
10. Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features.
Soussan M; Augier A; Brillet PY; Weinmann P; Valeyre D
Clin Nucl Med; 2014 Feb; 39(2):e146-59. PubMed ID: 23579973
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
Sgard B; Brillet PY; Bouvry D; Djelbani S; Nunes H; Meune C; Valeyre D; Soussan M
Clin Radiol; 2019 Jan; 74(1):81.e9-81.e18. PubMed ID: 30482560
[TBL] [Abstract][Full Text] [Related]
12. Focal Myocardial Damage in Cardiac Sarcoidosis Characterized by Strain Analysis on Magnetic Resonance Tagged Imaging in Comparison with Fluorodeoxyglucose Positron Emission Tomography Accumulation and Magnetic Resonance Late Gadolinium Enhancement.
Watanabe Y; Nishii T; Shimoyama S; Ito T; Mori S; Kono AK; Takahashi S; Hirata KI; Sugimura K
J Comput Assist Tomogr; 2018; 42(4):607-613. PubMed ID: 29613987
[TBL] [Abstract][Full Text] [Related]
13. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis.
Bolat S; Berding G; Dengler R; Stangel M; Trebst C
J Neurol Sci; 2009 Dec; 287(1-2):257-9. PubMed ID: 19755199
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
Braun JJ; Kessler R; Constantinesco A; Imperiale A
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1537-43. PubMed ID: 18418595
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
[No Abstract] [Full Text] [Related]
16. Monitoring the Therapy of Extensive Osseous Sarcoidosis With FDG PET/CT.
Yang H; Numani S; Liu S
Clin Nucl Med; 2017 Jul; 42(7):e337-e339. PubMed ID: 28240658
[TBL] [Abstract][Full Text] [Related]
17. F-18 FDG PET imaging of disseminated sarcoidosis.
Nguyen BD
Clin Nucl Med; 2007 Jan; 32(1):53-4. PubMed ID: 17179808
[No Abstract] [Full Text] [Related]
18. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis.
Divakaran S; Stewart GC; Lakdawala NK; Padera RF; Zhou W; Desai AS; Givertz MM; Mehra MR; Kwong RY; Hedgire SS; Ghoshhajra BB; Taqueti VR; Skali H; Dorbala S; Blankstein R; Di Carli MF
Circ Cardiovasc Imaging; 2019 Jun; 12(6):e008975. PubMed ID: 31177817
[TBL] [Abstract][Full Text] [Related]
19. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
20. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
